Vycor Medical Inc
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive co… Read more
Vycor Medical Inc (VYCO) - Total Assets
Latest total assets as of September 2025: $941.20K USD
Based on the latest financial reports, Vycor Medical Inc (VYCO) holds total assets worth $941.20K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Vycor Medical Inc - Total Assets Trend (2012–2024)
This chart illustrates how Vycor Medical Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Vycor Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Vycor Medical Inc's total assets of $941.20K consist of 69.7% current assets and 30.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 10.6% |
| Accounts Receivable | $245.26K | 24.6% |
| Inventory | $222.19K | 22.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Vycor Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Vycor Medical Inc's current assets represent 69.7% of total assets in 2024, an increase from 0.0% in 2012.
- Cash Position: Cash and equivalents constituted 10.6% of total assets in 2024, up from 2.3% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 29.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 24.6% of total assets.
Vycor Medical Inc Competitors by Total Assets
Key competitors of Vycor Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Vycor Medical Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Vycor Medical Inc generates 1.59x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Vycor Medical Inc is currently not profitable relative to its asset base.
Vycor Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.14 | 0.16 | 0.17 |
| Quick Ratio | 0.10 | 0.12 | 0.10 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-4.15 Million | $ -3.81 Million | $ -2.28 Million |
Vycor Medical Inc - Advanced Valuation Insights
This section examines the relationship between Vycor Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.85 |
| Asset Growth Rate (YoY) | 0.6% |
| Total Assets | $998.12K |
| Market Capitalization | $843.92K USD |
Valuation Analysis
Near Book Valuation: The market values Vycor Medical Inc's assets close to their book value ( 0.85x), suggesting investors view the company's assets at approximately fair value.
Positive Asset Growth: Vycor Medical Inc's assets grew by 0.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Vycor Medical Inc (2012–2024)
The table below shows the annual total assets of Vycor Medical Inc from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $998.12K | +0.59% |
| 2023-12-31 | $992.30K | +15.36% |
| 2022-12-31 | $860.18K | -8.04% |
| 2021-12-31 | $935.36K | -5.19% |
| 2020-12-31 | $986.52K | -9.65% |
| 2019-12-31 | $1.09 Million | +4.61% |
| 2018-12-31 | $1.04 Million | -27.99% |
| 2017-12-31 | $1.45 Million | -2.41% |
| 2016-12-31 | $1.49 Million | -26.57% |
| 2015-12-31 | $2.02 Million | -46.97% |
| 2014-12-31 | $3.81 Million | +80.33% |
| 2013-12-31 | $2.12 Million | -17.42% |
| 2012-12-31 | $2.56 Million | -- |